维普期刊资源整合服务平台（V6.5）

52篇 您的检索式：作者名="Trump DL"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Vitamin D signalling pathways in cancer: potential for anticancertherapeutics 显示文摘	Deeb KK Trump DL Johnson CS	2007	Nat Rev Cancer2007，7，9：	1
2	Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy显示文摘	Trump DL Deeb K Johnson CS	2010	Cancer J2010，16，1：	1
3	1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models显示文摘	Ma Y Yu WD Trump DL	2010	Cancer2010，116，13：	1
4	Vitamin D signalling pathways in cancer:potential for anticancer therapeutics显示文摘	Deeb KK Trump DL Johnson CS	2007	Nature Reviews Cancer2007，7，9：	1
5	Vitamin D signaling modulators in cancer therapy显示文摘	Luo W Johnson CS Trump DL	2016	Vitam and Horm2016，100，：	1
6	Pharmacokinetic and pharmacodynamic analysis of fluorouracil during 72-hour continuous infusion with and without dipyridamole 显示文摘	Trump DL Egorin M J Forrest A	1991	J Clin Oncol1991，9，11：	1
7	A phase I phar- macokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors 显示文摘	Fakih MG Trump DL Muindi JR	2007	Clin Cancer Res2007，13，4：	1
8	A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors显示文摘	Trump DL Muindi JR	2007	Clin Cancer Res2007，13，4：	1
9	Phase Ⅰ pharmacokinetic pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin(17AAG,NSC 330507),a novel inhibitor of heat shock protein90,in patients with refrac tory advanced cancers显示文摘	RAMANATHAN RK TRUMP DL EISEMAN JL		0，，09：	1
10	A phase 1 study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumors显示文摘	Jain RK Trump DL Egorin M J	2011	Invest New Drug2011，29，6：	1
11	Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells 显示文摘	Alagbala AA Johnson CS Trump DL	2006	Oncology2006，70，1：	1
12	Vitamin D-related therapies in prostate cancer显示文摘	Johnson CS Hershberger PA Trump DL	2002	Cancer Metastasis Rev2002，21，6：	1
13	Platinum analogue com- bination chemotherapy: eisplatin and carboplatin-a phase I trial with pharmacokinetic assessment of the effect of cisplatin adminis- tration on caboplatin excretion 显示文摘	Trump DL Grem JL Tutsch KD	1987	J Clin Oncol1987，5，8：	1
14	TARGET study group,depamnent of medicine,iastitut gustave roussy,villejuif,france显示文摘	Trump DL Escudier B Eisen T	2007	Urol Oncol2007，25，：	1
15	Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma显示文摘	Elson PJ Witte RS Trump DL	1988	Cancer Res1988，48，241：	1
16	Vitamin D in the prevention and treatment of prostate cancer 显示文摘	Johnson CS Trump DL	1999	Semin Urol Oncol1999，17，：	1
17	Vitamin D signalling pathways in cancer: potential for anticancer therapeutics 显示文摘	Deeb KK Trump DL Johnson CS	2007	Nat Rev Cancer2007，7，9：	1
18	Effect of once-weekly oral alendronate on bone loss in men receiving androgen depriva- tion therapy for prostate cancer:a randomized trial显示文摘	Greenspan SL Nelson JB Trump DL	2007	Ann Intern Meal2007，146，6：	1
19	Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer a randomized trial 显示文摘	Greenspan SL Nelson JB Trump DL	2007	Ann Intern Med2007，146，6：	1
20	Effect of ouce-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer:A randomized trial显示文摘	Nelson JB Trump DL	2007	Ann Intern Med2007，146，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示